Bessemer Group Inc. Has $252.59 Million Stock Holdings in CME Group Inc. $CME

Bessemer Group Inc. raised its holdings in CME Group Inc. (NASDAQ:CME) by 0.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 916,457 shares of the financial services provider’s stock after acquiring an additional 5,049 shares during the quarter. Bessemer Group Inc.’s holdings in CME Group were worth $252,593,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Webster Bank N. A. lifted its stake in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares during the last quarter. Highline Wealth Partners LLC lifted its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 43 shares during the last quarter. Wayfinding Financial LLC acquired a new stake in shares of CME Group in the first quarter worth $25,000. Cornerstone Planning Group LLC lifted its stake in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after buying an additional 55 shares during the last quarter. Finally, Trifecta Capital Advisors LLC lifted its stake in shares of CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 42 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research note on Friday. Barclays reduced their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. Raymond James Financial dropped their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Finally, Piper Sandler boosted their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $284.53.

CME Group Trading Up 0.2%

Shares of CME stock opened at $269.54 on Monday. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The firm’s fifty day simple moving average is $266.47 and its 200 day simple moving average is $271.90. The firm has a market capitalization of $97.14 billion, a P/E ratio of 26.12, a price-to-earnings-growth ratio of 6.65 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.68 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is 48.45%.

Insider Buying and Selling at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. The trade was a 4.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.